In addition, a frequency of < 9.4% of signal regulatory protein (SIRP)α/β-expressing memory B cells predicted RA patients that would develop ADAs, and consequentially failed to respond to treatment (156). This evidence concerns the gene SIRPA and rheumatoid arthritis.